HMOX1作为铁过量诱导脂肪组织功能障碍的标志物,影响人脂肪细胞的葡萄糖摄取和呼吸能力
研究探讨血红素加氧酶1(HMOX1)在铁过量诱导脂肪组织功能障碍中的作用。横断面分析显示肥胖者脂肪组织HMOX1表达升高并与代谢紊乱正相关,减重后降低而增重后升高。在人脂肪细胞中,铁过量和炎症上调HMOX1,HMOX1诱导可降低线粒体呼吸能力、葡萄糖摄取和脂肪生成。
要点
- 肥胖者脂肪组织HMOX1表达升高(p=0.01),与铁蓄积、炎症和氧化应激标志物正相关(p<0.01)。
- 减重手术后HMOX1降低(0.024±0.010 vs 0.010±0.004 RU,p<0.0001),大鼠高脂饮食增重后Hmox1升高(0.22±0.15 vs 0.54±0.22 RU,p=0.005)。
- 人脂肪细胞中HMOX1诱导可降低线粒体呼吸能力、葡萄糖摄取和脂肪生成。
核心结论
- HMOX1是铁过量诱导脂肪组织功能障碍和人肥胖代谢紊乱的重要标志物。
研究设计与样本
- 横断面分析两个独立队列(n=234和40)的皮下和内脏脂肪组织HMOX1基因表达与肥胖的关系。
- 评估减重(n=21)和大鼠增重(n=20)对HMOX1 mRNA的影响,以及人脂肪细胞分化过程中HMOX1 mRNA水平、炎症和铁对脂肪细胞HMOX1的影响、HMOX1诱导活性对脂肪细胞线粒体呼吸功能、葡萄糖摄取和脂肪生成的影响。
主要发现
- 肥胖参与者脂肪组织HMOX1升高(p=0.01),并与肥胖相关代谢紊乱及铁蓄积、炎症和氧化应激标志物正相关(p<0.01)。
- HMOX1与线粒体生物合成、胰岛素信号通路和脂肪生成相关mRNA负相关(p<0.01),这些关联在独立队列中重复。
- 减重手术后HMOX1降低(0.024±0.010 vs 0.010±0.004 RU,p<0.0001),大鼠高脂饮食增重后Hmox1 mRNA升高(0.22±0.15 vs 0.54±0.22 RU,p=0.005)。
- 人脂肪细胞中铁过量和炎症导致HMOX1 mRNA水平升高;HMOX1诱导(通过血红素精氨酸盐[hemin]给药)导致线粒体呼吸能力(包括基础呼吸和储备呼吸能力)、葡萄糖摄取和脂肪生成显著降低,同时炎症和铁过量相关基因表达增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Iron excess in adipose tissue is known to promote adipose tissue dysfunction. Here, we aimed to investigate the possible role of haem oxygenase 1 (HMOX1) in iron excess-induced adipose tissue dysfunction. METHODS: Cross-sectionally, HMOX1 gene expression in subcutaneous and visceral adipose tissue was analysed in two independent cohorts (n = 234 and 40) in relation to obesity. We also evaluated the impact of weight loss (n = 21), weight gain (in rats, n = 20) on HMOX1 mRNA; HMOX1 mRNA levels during human adipocyte differentiation; the effects of inflammation and iron on adipocyte HMOX1; and the effects of HMOX1-induced activity on adipocyte mitochondrial respiratory function, glucose uptake and adipogenesis. RESULTS: Adipose tissue HMOX1 was increased in obese participants (p = 0.01) and positively associated with obesity-related metabolic disturbances, and markers of iron accumulation, inflammation and oxidative stress (p < 0.01). HMOX1 was negatively correlated with mRNAs related to mitochondrial biogenesis, the insulin signalling pathway and adipogenesis (p < 0.01). These associations were replicated in an independent cohort. Bariatric surgery-induced weight loss led to reduced HMOX1 (0.024 ± 0.010 vs 0.010 ± 0.004 RU, p < 0.0001), whereas in rats, high-fat diet-induced weight gain resulted in increased Hmox1 mRNA levels (0.22 ± 0.15 vs 0.54 ± 0.22 RU, p = 0.005). These changes were in parallel with changes in BMI and adipose tissue markers of iron excess, adipogenesis and inflammation. In human adipocytes, iron excess and inflammation led to increased HMOX1 mRNA levels. HMOX1 induction (by haem arginate [hemin] administration), resulted in a significant reduction of mitochondrial respiratory capacity (including basal respiration and spare respiratory capacity), glucose uptake and adipogenesis in parallel with increased expression of inflammatory- and iron excess-related genes. CONCLUSIONS/INTERPRETATION: HMOX1 is an important marker of iron excess-induced adipose tissue dysfunction and metabolic disturbances in human obesity.
引用
- Moreno-Navarrete JM, Ortega F, Rodríguez A, et al. HMOX1 as a marker of iron excess-induced adipose tissue dysfunction, affecting glucose uptake and respiratory capacity in human adipocytes. Diabetologia. 2017. PMID: 28243792. doi:10.1007/s00125-017-4228-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。